On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission to the FDA for the company's mBôs TKA System. The company stated it had completed all ...
Company has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR) AUSTIN, TX / ACCESS Newswire / February 26, 2025 / Monogram ...
On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies Inc.’s (NASDAQ:MGRM) Monogram mBôs TKA System. Ben Sexson, Monogram’s Chief Executive Officer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback